Assessing the efficacy and impact of a personalised smoking cessation intervention among type 2 diabetic smokers: study protocol for an open-label randomised controlled trial (DISCGO-RCT).
Carole ClairAurélie AugsburgerPriska BirrerIsabella LocatelliJoelle SchwarzGilbert GreubAnne ZanchiIsabelle Jacot-SadowskiJardena J PuderPublished in: BMJ open (2020)
ClinicalTrials.gov NCT03426423 and SNCTP000002762; Pre-results.